New challenges for an expanding generation of older persons with haemophilia

1 Blanchette VS, Key NS, Ljung LR, et al.; Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 2014; 12: 1935–9. doi: 10.1111/jth.12672. BlanchetteVS KeyNS LjungLR Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis Definitions in hemophilia: communication from the SSC of the ISTH J Thromb Haemost 2014 12 1935 9 10.1111/jth.12672 25059285 Open DOISearch in Google Scholar

2 Siboni SM, Mannucci PM, Gringeri A, et al.; Association of Haemophilia Centres (AICE). Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7: 780–786. doi: 10.1111/j.1538-7836.2009.03318.x. SiboniSM MannucciPM GringeriA Association of Haemophilia Centres (AICE) Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy J Thromb Haemost 2009 7 780 786 10.1111/j.1538-7836.2009.03318.x 19220727 Open DOISearch in Google Scholar

3 Oladapo AO, Epstein JD, Williams E, et al. Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials. Haemophilia 2015; 21: e344–e358. doi: 10.1111/hae.12759. OladapoAO EpsteinJD WilliamsE Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials Haemophilia 2015 21 e344 e358 10.1111/hae.12759 26390060 Open DOISearch in Google Scholar

4 Escobar M, Sallah S. Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis. J Thromb Haemost 2013; 11: 1449–1453. doi: 10.1111/jth.12317. EscobarM SallahS Hemophilia A and hemophilia B: focus on arthropathy and variables affecting bleeding severity and prophylaxis J Thromb Haemost 2013 11 1449 1453 10.1111/jth.12317 23763284 Open DOISearch in Google Scholar

5 Mannucci PM, Iacobelli M. Progress in the contemporary management of hemophilia: The new issue of patient aging. Eur J Intern Med 2017; 43: 16–21. doi: 10.1016/j.ejim.2017.05.012 MannucciPM IacobelliM Progress in the contemporary management of hemophilia: The new issue of patient aging Eur J Intern Med 2017 43 16 21 10.1016/j.ejim.2017.05.012 28532688 Open DOISearch in Google Scholar

6 Chu WM, Ho HE, Wang JD, et al. Risk of major comorbidities among workers with hemophilia: A 14-year population-based study. Medicine (Baltimore) 2018; 97(6): e9803. doi: 10.1097/MD.0000000000009803. ChuWM HoHE WangJD Risk of major comorbidities among workers with hemophilia: A 14-year population-based study Medicine (Baltimore) 2018 97 6 e9803 10.1097/MD.0000000000009803 594466629419677 Open DOISearch in Google Scholar

7 Wang JD, Chan WC, Fu YC, et al. Prevalence and risk factors of atherothrombotic events among 1054 hemophilia patients: a population-based analysis. Thromb Res 2015; 135: 502–7. doi: 10.1016/j.thromres.2014.12.027 WangJD ChanWC FuYC Prevalence and risk factors of atherothrombotic events among 1054 hemophilia patients: a population-based analysis Thromb Res 2015 135 502 7 10.1016/j.thromres.2014.12.027 25601170 Open DOISearch in Google Scholar

8 O’Hara J, Hughes D, Camp C, et al. The cost of severe haemophilia in Europe: the CHESS study. Orphanet J Rare Dis 2017; 12: 1–8. doi: 10.1186/s13023-017-0660-y. O’HaraJ HughesD CampC The cost of severe haemophilia in Europe: the CHESS study Orphanet J Rare Dis 2017 12 1 8 10.1186/s13023-017-0660-y 545240728569181 Open DOISearch in Google Scholar

9 NatCen Social Research, University College London. Department of Epidemiology and Public Health. (2014). Health Survey for England, 2012. [data collection]. UK Data Service. SN: 7480. doi: 10.5255/UKDA-SN-7480-1. NatCen Social Research, University College London. Department of Epidemiology and Public Health 2014 Health Survey for England, 2012 [data collection]. UK Data Service. SN: 7480. 10.5255/UKDA-SN-7480-1 Open DOISearch in Google Scholar

10 EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy (New York) 1990; 16(3): 199–208. doi: 10.1016/0168-8510(90)90421-9 EuroQol Group EuroQol-a new facility for the measurement of health-related quality of life Health Policy (New York) 1990 16 3 199 208 10.1016/0168-8510(90)90421-9 10109801 Open DOISearch in Google Scholar

11 Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. Discussion paper 172. York: Centre for Health Economics. 1999. Available from https://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHE%20Discussion%20Paper%20172.pdf (accessed 9 October 9 2019). KindP HardmanG MacranS UK Population Norms for EQ-5D Discussion paper 172. York Centre for Health Economics 1999 Available from https://www.york.ac.uk/media/che/documents/papers/discussionpapers/CHE%20Discussion%20Paper%20172.pdf (accessed 9 October 9 2019). Search in Google Scholar

12 R Core Team. The R Project for Statistical Computing. 2017. Available from https://www.r-project.org. R Core Team The R Project for Statistical Computing 2017 Available from https://www.r-project.org. Search in Google Scholar

13 Stonebraker JS, Bolton-Maggs PHB, Michael Soucie J, Walker I, Brooker M. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia 2010; 16: 20–32. doi: 10.1111/j.1365-2516.2009.02127.x StonebrakerJS Bolton-MaggsPHB Michael SoucieJ WalkerI BrookerM A study of variations in the reported haemophilia A prevalence around the world Haemophilia 2010 16 20 32 10.1111/j.1365-2516.2009.02127.x 19845775 Open DOISearch in Google Scholar

14 Stonebraker JS, Bolton-Maggs PHB, Michael Soucie J, Walker I, Brooker M. A study of variations in the reported haemophilia B prevalence around the world. Haemophilia 2012; 18: e91–e94. doi: 10.1111/j.1365-2516.2011.02588.x StonebrakerJS Bolton-MaggsPHB Michael SoucieJ WalkerI BrookerM A study of variations in the reported haemophilia B prevalence around the world Haemophilia 2012 18 e91 e94 10.1111/j.1365-2516.2011.02588.x 21649801 Open DOISearch in Google Scholar

15 Berntorp E, Dolan G, Hay C, et al. European retrospective study of real-life haemophilia treatment. Haemophilia 2017; 23: 105–114. doi: 10.1111/hae.13111 BerntorpE DolanG HayC European retrospective study of real-life haemophilia treatment Haemophilia 2017 23 105 114 10.1111/hae.13111 27761962 Open DOISearch in Google Scholar

16 Konkle BA. Clinical challenges within the aging hemophilia population. Thromb Res 2011; 127: S10–S13. doi: 10.1016/j.thromres.2010.10.004. KonkleBA Clinical challenges within the aging hemophilia population Thromb Res 2011 127 S10 S13 10.1016/j.thromres.2010.10.004 21056901 Open DOISearch in Google Scholar

17 Philipp C. The aging patient with hemophilia: complications, comorbidities, and management issues. Hematology 2010; 191–196. doi: 10.1182/asheducation-2010.1.191 PhilippC The aging patient with hemophilia: complications, comorbidities, and management issues Hematology 2010 191 196 10.1182/asheducation-2010.1.191 21239793 Open DOISearch in Google Scholar